Posters

Toric AT TORBI 709M/MP (Carl Zeiss) intraocular lens implantation (IOL) in cataract patients with moderate and high corneal astigmatism

Poster Details

First Author: D. Dementiev RUSSIAN FEDERATION

Co Author(s):    A. Shipunova   M. Sysoeva   I. Ivanchikova              

Abstract Details

Purpose:

To evaluate refractive outcomes, rotational stability and safety of lens exchange with customized AT TORBI 709M/MP (Carl Zeiss) IOL to correct high and moderate regular corneal astigmatism in cataract patients.

Setting:

“Blue Eye” Centro di Chirurgia Oculare, Milano, Italy, “International Center for Ophthalmology”, Moscow, Russia

Methods:

Phacoemulsification cataract extraction and implantation of an AT Torbi 709M IOL were performed. The uncorrected (UDVA) and corrected (CDVA) distance visual acuities; corneal cylinder, refraction, and IOL axis were evaluated preoperatively and postoperatively up to 36 months.

Results:

The study enrolled 47 eyes of 31 patients with a mean age of 53 years ±7,4. The mean refractive SE decreased from -3.43 ± 3.44 D to -0.21 ± 0.81D. The mean refractive astigmatism decreased from -5.13 ± 1.77 D to -1.12 ± 0.63 D. There was an improvement in the mean UDVA from 0.89 ± 0.65 log MAR to 0.15 ± 0.16 log MAR and in the mean CDVA from 0.38 ± 0.18 log MAR to 0.05 ± 0.11 log MAR. IOL rotation was not seen in all cases. No intra- or postoperative surgical complications were observed.

Conclusions:

Lens Exchange for customized toric AT TORBI 709M/MP (Carl Zeiss) IOL is rotationally stable and shows excellent capsule bag performance and refractive outcomes.

Financial Disclosure:

One or more of the authors has significant investment interest in a company producing, developing or supplying product or procedure presented